Concepedia

Michael P. DeMartino

MP

11

Publications

1.3K

Citations

11

H-Index

2006

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Scripps Research Institute

University of Oklahoma Health Sciences Center

WuXi AppTec (China)

Michael P. DeMartino is an author at GlaxoSmithKline (United States) specializing in medicine, engineering, and pharmacology.

Top concepts

MedicineEngineeringPharmacologyBiochemistryDrug DiscoverySystems BiologyNatural SciencesOrganic ChemistryBiomolecular EngineeringApoptosis

Publications per year

2006–2024

11

Publications

11

RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity

Pratyusha Mandal, Scott B. Berger, Sirika Pillay et al. · Molecular Cell · 2014 · 593 citations · Full text

Cell Regulation, Pronecrotic Kinase Activity, Receptor Tyrosine Kinase +6

Intermolecular Enolate Heterocoupling: Scope, Mechanism, and Application

Michael P. DeMartino, Ke Chen, Phil S. Baran · Journal of the American Chemical Society · 2008 · 295 citations

Intermolecular Oxidative Enolate Heterocoupling

Phil S. Baran, Michael P. DeMartino · Angewandte Chemie International Edition · 2006 · 198 citations · Full text

Diversity Oriented Synthesis, Engineering, Natural Sciences +10

Intermolecular Oxidative Enolate Heterocoupling

Phil S. Baran, Michael P. DeMartino · Angewandte Chemie · 2006 · 72 citations

Engineering, Eine Rasche Synthese, Biochemistry +12

Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel

Pamela A. Haile, Linda Casillas, Michael J. Bury et al. · ACS Medicinal Chemistry Letters · 2018 · 35 citations · Full text

Rows per page

1–5 of 11